Text size: click to decrease font sizeclick to increase font size (click to alter)
London sarcoma service

Royal National Orthopaedic Hospital NHS Trust

University College London Hospitals NHS Foundation Trust

our approach & expertise

>

research & clinical trials

>

trials shortly to open

AYAPK - Pharmacokinetics and Pharmacodynamics of Doxorubicin in Children, Adolescents and young adults with Newly Diagnosed Osteosarcoma, Ewing Family of Tumours and Hodgkin Lymphoma. This trial is looking at differences between how males and females respond to doxorubicin chemotherapy, and whether there is an impact of puberty.

CASPS - A Phase II Trial of Cediranib in the Treatment of Patients with Alveolar Soft Part Sarcoma (CASPS). This trial is testing a new drug cediranib that has already shown promising results in a small number of patients with alveolar soft part sarcoma. Cedirinib works by inhibiting growth of blood vessels in tumours.